Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


Sensex Today Ends 140 Points Higher Ahead of FOMC Meeting | Pharma & PSU Bank Stocks Top Gainers | HDFC Life Gains 3%
Wed, 22 Mar Closing

Sensex Today Ends 140 Points Higher Ahead of FOMC Meeting | Pharma & PSU Bank Stocks Top Gainers | HDFC Life Gains 3%

After opening the day on a positive note, Indian share markets continued their momentum throughout the trading session and held on to their gains.

Benchmark indices rose on Wednesday ahead of the US Federal Reserve rate decision, as concerns of a banking crisis eased further after the Credit Suisse rescue.

At the closing bell, the BSE Sensex stood higher by 136 points (up 0.2%).

Meanwhile, the NSE Nifty closed up by 44 points (up 0.3%).

HDFC Life Insurance, Bajaj Finance and Sun Pharma were among the top gainers today.

BPCL, NTPC and Coal India on the other hand, were among the top losers today.

The SGX Nifty was trading at 17,168 up by 24 points, at the time of writing.

Broader markets ended on a positive note. The BSE Midcap index ended flat while the BSE SmallCap gained 0.5%.

Sectoral indices ended on a mixed note with stocks in the healthcare sector, auto sector and FMCG sector witnessing most of the buying.

On the other hand, stocks from the realty sector and metal sector witnessed selling pressure.

Shares of KPIT Technologies hit their 52-week highs today.

Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

2 stocks to buy as Nifty50 heads towards 40,000

We have identified 2 stocks. These stocks are not in the Nifty50 index today.

But they have a very high chance of entering Nifty as it heads towards 40,000.

We believe you should buy these 2 stocks right away.

See Details Here
Details of our SEBI Research Analyst registration are mentioned on our website - www.equitymaster.com
---------------------------------------------------

Asian stock markets ended on a positive note. The Nikkei ended higher by 1.9%, while the Hang Seng was up 1.7%. The Shanghai Composite ended 0.3% higher.

The rupee is trading at 82.65 against the US$.

Gold prices for the latest contract on MCX are trading higher by 0.3% at Rs 58,730 per 10 grams.

Meanwhile, silver prices for the latest contract on MCX are trading up by 0.6% at Rs 68,814 per kg.

Speaking of stock markets, the Indian stock markets have been facing one event after the other that is making Mr Market nervous.

First it was Adani saga. The recent events of failure of SVB and Signature Bank, and now the concerns related to Credit Suisse are again feeding the fear element in the stock markets.

Last time the global banks failed, we witnessed a correction across global including Indian stock markets.

In her latest video, smallcap analyst at Equitymaster Richa Agarwal talks about how you should approach investing amid these macro events.

L&T bags multiple orders

In news from the engineering sector, Larsen and Toubro (L&T), on Wednesday, secured orders for its water and effluent treatment and buildings and factories businesses.

Though the company did not disclose the total value of the orders, it indicated that they were of a 'significant' size.

The water and effluent treatment business has secured a repeat order from the Drinking Water and Sanitation Department of the Jharkhand government.

The order involves executing a Raw Water Transport System on a turnkey basis from the proposed intake at Neghra, Rajmahal.

Meanwhile, the building and factories business of L&T Construction has won an order from a reputed developer to construct residential towers in Bengaluru.

The scope of the work involves building civil structures, including waterproofing, masonry and plastering for ten towers comprising two basements.

The company has rewarded investors with 10 bonuses over the last 7 decades and the CAGR over the last 20 years stands at an impressive 25.6%.

chart

L&T has been an investor's favorite stock for a long time and also a stock that makes it to the top 5 infrastructure stocks.

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Up For Grabs

Equitymaster's Small Cap Research At 60% Off

Claim Now
Details of our SEBI Research Analyst registration are mentioned on our website - www.equitymaster.com
---------------------------------------------

10 out of 11 recent IPOs disappoint investors...

Moving on to news from the initial public offering (IPO) space, the primary market has turned out to be disappointing for investors so far in 2023.

All the hype around some of the recent IPOs has fizzled out in just a few months, with 10 out of 11 recent debutants trading at a discount over the issue price.

Except for Divgi TorqTransfer, other companies - Inox Green Energy, Keystone Realtors, Dharmaj Crop Guard, Uniparts India, Sula Vineyards, Abans Holdings, Landmark Cars, KFin Technologies, Elin Electronics, Radiant Cash Management Services are currently at a discount of up to 40% over the IPO price.

Interestingly, shares of 6 out of these 11 companies have debuted at a premium, while four others listed at a discount on the bourses, and one company had a flattish debut.

This muted performance of recently listed stocks can be due to pricey valuations and unfavourable market sentiments.

As most of these IPOs have hit the market in recent times, they are priced to perfection, leaving hardly anything for retail investors.

As market sentiments too play a huge role in public offers, the current volatility has further dragged the debutants.

Indian equity markets have been volatile in the last couple of months, plagued by a host of issues, dragging Sensex and Nifty down by around 6% on a year-to-date basis.

For more details, check out the current IPOs and upcoming IPOs on our website.

Zydus Lifesciences' arm gets USFDA nod for generic drug

Moving on to news from pharma sector, Zydus Pharmaceuticals (USA), a subsidiary of Zydus Lifesciences received final approval and tentative approval from the United States Food and Drug Administration (USFDA) for Tofacitinib tablets.

Zydus Pharmaceuticals was one of the first ANDA applicants to submit a substantially complete abbreviated new drug application for Tofacitinib tablets.

It is also indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).

Value Stocks: Stocks with Limited Downside but Good Upside Potential

The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India).

According to IQVIA MAT December 2022, Tofacitinib Tablets, 5 mg and 10 mg had annual sales of $900 million in the United States.

The group now has 352 approvals and has so far filed over 440* ANDAs since the commencement of the filing process in the financial year 2003-04.

Check out Equitymaster's stock screener for screening India's top pharma stocks.

And to know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Sensex Today Ends 140 Points Higher Ahead of FOMC Meeting | Pharma & PSU Bank Stocks Top Gainers | HDFC Life Gains 3%". Click here!